The global sugar-based excipient market size is expected to reach USD 1,542.5 Million by 2028 at a CAGR of 4.5%, according to the latest report by Reports and Data. Increasing use of co-processed excipients to improve dissolution, bioavailability, growth in pharmaceuticals manufacturers, surging demand and production of Orally Disintegrated Tablets (ODT), rising demand of pharmaceuticals drugs, scientific development in genetics industry, and availability of low-cost manufacturing infrastructure, and technological advancements in sugar-based excipients are some key factors expected to drive market revenue growth over the forecast period.
Excipients are the inactive substances that are used in production of drugs specifically to conceal the effect or the bitterness of active agents present in drugs. Sugar-based excipients have been FDA-approved substances used in medicines given to children. Sugar-based excipients are most popularly used in antibiotics and cough syrups. They are primarily applicable in disintegration of Active Pharmaceutical Ingredients (API) present in medicines, and widely used in sucrose, glycerol, saccharin sodium, and sorbitol. Sugar-based excipients are also used as fillers, binders and coating materials, they reduces stickiness and enhance flavors of medicines, making it highly palatable.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
As part of our quantitative analysis, we have provided regional market forecasts by type and application, market sales forecasts and estimates by type, application and region by 2028, and global sales and production forecasts and estimates for Sugar-Based Excipients by 2028. For the qualitative analysis, we focused on political and regulatory scenarios, component benchmarking, technology landscape, important market topics as well as industry landscape and trends.
We have also focused on technological lead, profitability, company size, company valuation in relation to the industry and analysis of products and applications in relation to market growth and market share.
The Sugar-Based Excipients report contains data based on rigorous primary and secondary school studies using research best practices. The report contains exhaustive information that will allow you to assess each segment of the Sugar-Based Excipients market. This report has been prepared considering various aspects of market research and analysis. It includes market size estimates, market dynamics, and company and market best practices. Entry marketing strategy, positioning, segmentation, competitive landscape, and economic forecasts. Industry-specific technology solutions, roadmap analysis, alignment with key purchasing criteria, in-depth benchmarking of vendor products
Key Players covered in this report are:
DFE Pharma, Archer Daniels Midland Company, Ashland Inc., Roquette Group, The Lubrizol Corporation, Associated British Foods PLC, Cargill, Inc., Colorcon Inc., FMC Corporation, and Meggle AG.
Type Outlook (Revenue, USD Billion; 2018 – 2028)
Actual SugarsSugar AlcoholsArtificial SweetenersApplication Outlook (Revenue, USD Billion; 2018 – 2028)
Coatings Powders/GranulesDirect Compression SugarsCrystals, SyrupsGeographic Segment Covered in the Report:
• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/437
Thank you for reading the research report on global Sugar-Based Excipients market. Kindly contact us to know more about the customization feature and our team will offer the best suited report as per your requirement.
Browse More Report:
Folinic Acid Market @ https://www.biospace.com/article/folinic-acid-market-analysis-business-growth-regional-trends-development-status-sales-revenue-and-comprehensive-research-study-till-2026/
Etanercept Market @ https://www.biospace.com/article/etanercept-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2026s/
Colorectal Cancer Market @ https://www.biospace.com/article/colorectal-cancer-market-size-competitors-strategy-regional-analysis-and-industry-growth-by-forecast-to-2026/
Bacterial Conjunctivitis Market @ https://www.biospace.com/article/bacterial-conjunctivitis-market-trends-revenue-key-players-growth-share-and-forecast-till-2027/
Ankylosing Spondylitis (AS) Market @ https://www.biospace.com/article/ankylosing-spondylitis-as-market-analysis-industry-size-share-leaders-current-status-by-major-key-vendors-and-trends-by-forecast-to-2027/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
0
Sign in to leave a comment.